Ftse Mib
34.282,01
-0,27%
DAX
18.483,00
-0,63%
S&P 500
5.654,67
0,42%
NASDAQ
18.538,18
0,36%
Bitcoin
63.876,09
-1,50%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Applied Therapeutics Inc (APLT) Applied Therapeutics Inc (APLT) Notizie

APLT

Applied Therapeutics (APLT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT
DataOraFonteTitoloSimboloCompagnia
01/02/202113:00GlobeNewswire Inc.Applied Therapeutics Announces Restart of Pediatric Galactosemia StudyNASDAQ:APLTApplied Therapeutics Inc
15/12/202014:00GlobeNewswire Inc.Applied Therapeutics to be Added to NASDAQ Biotechnology IndexNASDAQ:APLTApplied Therapeutics Inc
09/12/202014:15GlobeNewswire Inc.Applied Therapeutics Announces Launch of Galactosemia Awareness and Education InitiativeNASDAQ:APLTApplied Therapeutics Inc
09/12/202013:00GlobeNewswire Inc.Applied Therapeutics Announces MRS Data from ACTION-Galactosemia StudyNASDAQ:APLTApplied Therapeutics Inc
12/11/202014:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APLTApplied Therapeutics Inc
12/11/202013:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APLTApplied Therapeutics Inc
12/11/202013:00GlobeNewswire Inc.Applied Therapeutics Reports Third Quarter 2020 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
09/11/202013:00GlobeNewswire Inc.Applied Therapeutics Announces Presentation of Pre-Clinical Data on AT-001 for the Treatment of Diabetic Cardiomyopathy at th...NASDAQ:APLTApplied Therapeutics Inc
21/10/202013:00GlobeNewswire Inc.Applied Therapeutics to Present Data on AT-007 for the Treatment of Galactosemia at the American Society of Human Genetics (A...NASDAQ:APLTApplied Therapeutics Inc
05/10/202019:00GlobeNewswire Inc.180 Life Science Corp. Announces New Board of Directors AppointmentsNASDAQ:APLTApplied Therapeutics Inc
24/09/202014:00GlobeNewswire Inc.FDA Grants AT-007 Pediatric Rare Disease Designation and Orphan Designation for Treatment of PMM2-CDGNASDAQ:APLTApplied Therapeutics Inc
17/09/202013:00GlobeNewswire Inc.Applied Therapeutics to Present Data on AT-001 for Treatment of Diabetic Cardiomyopathy at 56th Annual Meeting of the Europea...NASDAQ:APLTApplied Therapeutics Inc
02/09/202013:00GlobeNewswire Inc.Applied Therapeutics to Present at Citi and Baird Investor ConferencesNASDAQ:APLTApplied Therapeutics Inc
11/08/202013:00GlobeNewswire Inc.Applied Therapeutics Reports Second Quarter 2020 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
10/08/202015:26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APLTApplied Therapeutics Inc
17/07/202013:00GlobeNewswire Inc.Applied Therapeutics to Present Data on AT-007 for Treatment of Galactosemia at the Galactosemia Foundation 2020 Virtual Conf...NASDAQ:APLTApplied Therapeutics Inc
06/07/202012:00GlobeNewswire Inc.Applied Therapeutics Takes Action Against Fraudulent “Short Report”NASDAQ:APLTApplied Therapeutics Inc
16/06/202012:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APLTApplied Therapeutics Inc
15/06/202013:00GlobeNewswire Inc.Applied Therapeutics Announces Start of AT-007 Pediatric Galactosemia Study; Releases Additional 40mg/kg Data from Adult Gala...NASDAQ:APLTApplied Therapeutics Inc
12/06/202022:53Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:APLTApplied Therapeutics Inc
08/06/202013:00GlobeNewswire Inc.Applied Therapeutics to Present Data on AT-001 for the Treatment of Diabetic Cardiomyopathy at 2020 American Diabetes Associa...NASDAQ:APLTApplied Therapeutics Inc
06/06/202000:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APLTApplied Therapeutics Inc
05/06/202012:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:APLTApplied Therapeutics Inc
05/06/202012:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:APLTApplied Therapeutics Inc
03/06/202013:00GlobeNewswire Inc.Applied Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare ConferenceNASDAQ:APLTApplied Therapeutics Inc
01/06/202023:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APLTApplied Therapeutics Inc
27/05/202000:44Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APLTApplied Therapeutics Inc
26/05/202013:00GlobeNewswire Inc.Applied Therapeutics Announces Appointment of Dr. Chuck Silberstein, MD, MBA, CFA as Chief Financial Officer and Head of Busi...NASDAQ:APLTApplied Therapeutics Inc
12/05/202013:00GlobeNewswire Inc.Applied Therapeutics to Present at the UBS Global Healthcare ConferenceNASDAQ:APLTApplied Therapeutics Inc
11/05/202013:49Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APLTApplied Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
FBK
Finecobank
BIT
STLAM
Stellantis NV
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
BC
Brunello Cucinelli
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
G
Generali
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
MONC
Moncler
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network